AGILeBiotics B.V. is a pharmaceutical company based in Groningen, the Netherlands, founded in 2017. The company specializes in the development of novel antibiotics aimed at treating life-threatening infections caused by multidrug-resistant bacteria, particularly those acquired in hospital settings. By focusing on natural products, AGILeBiotics seeks to provide innovative therapeutic alternatives for healthcare professionals, thereby enhancing patient outcomes in intensive care units. The company's mission is to address the urgent need for effective treatments against drug-resistant infections, contributing to the global fight against antibiotic resistance.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.